Manhattan Research to Host Webinar Revealing How to Leverage this Year’s Physician Digital Resource and Communication Mix for Brand Success in 2010 – Tuesday, August 4

Manhattan Research to Host Webinar Revealing How to Leverage this Year's Physician Digital Resource and Communication Mix for Brand Success in 201...

 

Manhattan Research to Host Webinar Revealing How to Leverage this Year’s Physician Digital Resource and Communication Mix for Brand Success in 2010 – Tuesday, August 4












New York, NY (PRWEB) July 23, 2009

Mark Bard, president of pharmaceutical and healthcare market research company Manhattan Research, will host a complimentary physician marketing webinar on Tuesday, August 4 at 11am and 3pm EDT. The webinar, ePharma PhysicianВ® v9.0: Navigating the Physician Digital Resource Mix, will preview the data and insights available in the company’s recently released ePharma PhysicianВ® study and advisory service.

ePharma PhysicianВ® differentiates itself from Manhattan Research’s broader physician studies by probing deeper into the digital resource and communication preferences of physicians interacting with pharmaceutical, device, and biotech companies online. This group of “ePharma Physicians” has now reached a significant 87% of the total U.S. physician population, making it necessary for manufacturers, agencies, and medical content providers to understand this market and leverage technology in building successful relationships.

“As digital becomes a core part of the brand planning discussion, marketers and our agency clients are demanding deeper insight into the specific sites physicians are using online – and they want to know what these visitors think of their site as well as the competition,” said Mr. Bard. “In addition to tracking online journals, specialty sites, corporate sites, and product sites by specialty, we combine that research with a review of ‘what if’ scenarios to help our clients better understand what physicians want from the next generation of the clinical web.”

During the August 4th webinar, Mr. Bard will review the following key questions:

In what ways is the shifting professional resource and communication mix affecting physician interaction with pharmaceutical and device companies?
How can marketers leverage their specific physician audience’s journal, specialty, product and corporate site mix to dictate more intelligent media plans in 2010?
Is email a viable communication channel in the manufacturer-physician relationship?
How are companies using interactive detailing, video conferencing, and portals to evolve siloed sales force strategies to 360В° customer service models?
What are the keys to success when building and managing a pharmaceutical customer service portal? What types of features do physician expect from these sites?
Register for this Webinar Today!

Session 1: Tuesday, August 4, 11:00 – 11:30 AM EDT

Register here: https://www2.gotomeeting.com/register/550629875

Session 2: Tuesday, August 4, 3:00 – 3:30 PM EDT

Register here: https://www2.gotomeeting.com/register/766231642

The webinar is intended for qualified business accounts. For assistance in signing up, please email your time preference to webinars(at)manhattanresearch(dot)com or call Maureen Malloy at 212-255-7799.

About ePharma PhysicianВ® v9.0:

ePharma PhysicianВ® v9.0 was conducted via online survey methodology in Q2 2009 among 1,517 online practicing U.S. physicians.

Since 2002, the study has determined the leading online physician destinations based on the number of physician visitors as well as the content satisfaction of those who visit. In-depth analysis of top product and corporate pharmaceutical websites, health portals, online journal sites, specialty-specific sites, newsletters and society sites is available as part of the ePharma PhysicianВ® v9.0 advisory service. Additional topics include interactive detailing, tech-enabled sales reps, video conferencing, web 2.0 technologies, email use and interest, and pharmaceutical customer service portals, as well as market data for 300+ leading pharmaceutical product websites including Abilify, Actonel, Actos, Advair, Ambien CR, Amitiza, Androgel, Aricept, Asmanex, Astelin, Avandia, Avastin, Avelox, Avodart, Boniva, Botox, Byetta, Celebrex, Chantix, Cialis, Cipro, Concerta, Coreg CR, Crestor, Cymbalta, Daytrana, Depo-Provera, Detrol LA, Diovan, Effexor XR, Enbrel, Evista, Flomax, Flonase, Flovent HFA, Forteo, Fosamax/Fosamax Plus D, Gardasil, Geodon, Humira, Imitrex, Invega, Januvia, Lamictal, Latisse, Levaquin, Levitra, Lexapro, Lipitor, Loestrin 24 Fe, Lovaza, Lovenox, Lunesta, Lupron, Lyrica, Mirena, Namenda, Nasacort, Nasonex, Nexium (purplepill.com), NuvaRing, Pegasys, Plavix, Prevacid, Pristiq, ProAir HFA, Protonix, Provigil, Pulmicort, Relpax, Remicade, Requip, Risperdal, Rozerem, Seasonale, Seasonique, Seroquel, Singulair, Spiriva, Strattera, Symbicort, Tamiflu, Tekturna, Topamax/Topamax360, TriLipix, Ultram ER, Valtrex, Veramyst, Vesicare, Viagra, Vytorin, Vyvanse, Wellbutrin XL, Xyzal, Yaz, Zetia, Zithromax, Zoloft, Zyprexa, Zyvox. A complete list of available product sites is available at http://www.manhattanresearch.com/files/PRESS/ePharma_Physician_v9.0_Product_Site_Listing.pdf.

ePharma PhysicianВ® v9.0 also includes the following specialist segments in the research: Allergy and Immunology, Cardiology (Cardiovascular Surgery and Interventional Cardiology), Dermatology, Emergency Medicine, Endocrinology, Family Medicine/General Practice, Gastroenterology, Infectious Disease or HIV physician, Internal Medicine, Nephrology, Neurology, OB/GYN, Oncology-Hematology & Medical, Ophthalmology, Pediatrics, Psychiatry, Pulmonology, Radiology, Rheumatology, Surgery (General), and Urology.

For additional product and subscription information, please visit http://www.manhattanresearch.com/products/Strategic_Advisory/ePP.

About Manhattan Research:

Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com or call 1.888.680.0800.

About Decision Resources, Inc.:

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresourcesinc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

###






















VocusВ©Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.







Goodbye Harsh Sinus Medications: Florida Medical Doctor Invents a Natural & Gentle Nasal Spray to Relieve Sinus Problems and Nasal Congestion

 

Goodbye Harsh Sinus Medications: Florida Medical Doctor Invents a Natural & Gentle Nasal Spray to Relieve Sinus Problems and Nasal Congestion











Apalachicola, FL (PRWEB) May 12, 2005

Dr. Rasoul Salman has suffered from sinus problems all his life and was very frustrated by the side effects he experienced from nasal decongestants. To combat side effects, Dr. Salman made it his life’s mission to develop a natural sinus medication that would relieve his sinus congestion while being gentle on his nose. After many years of hard work and dedicated research, Dr. Salman developed SinusMagic.

SinusMagic is a gentle nasal spray helps soothe your nose by moisturizing it and cleaning out the phlegm that may be mixed with pollutants like pollen, dust and smog, which are the main causes of many sinus problems. Reputable studies conducted by Dr. Rasoul Salman show that SinusMagic not only improves nasal symptoms but also decreases the incidents of nasal bleeding and infection.

According to Dr. Rasoul Salman, “I am one of millions frustrated by sinus trouble. I have tried over the counter decongestants such as Afrin, Sudafed and other cold and sinus medications. All of the decongestants had side effects such as increased blood pressure, heart irregularity, nasal dryness and nasal bleeding. I also tried prescription nasal drugs (nasal steroids) such as Nasacort, Rhinocort and Flonase. The prescription steroids also had side effects such as loss of smell, viral, bacterial and fungal infections. I even tried surgery, which again did not help. It has taken me many years to develop a natural nasal spray that is gentle and works. I hope SinusMagic helps you as it has helped me and others.”

SinusMagic Ingredients include: Salt and Water, Mucosolvin, Zinc Sulfate, Alum, Tolo Balsam, Tea tree oil, Glycerin, and Winter Green Oil (Methyl Salicylate).

For more information on SinusMagic Nasal Spray including research studies, an electronic brochure and product photos, please visit www.sinusmagic.com.

Media kits, high-resolution photography and product review samples are available on request.

# # #







Attachments






















VocusВ©Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.







Find More Rhinocort Press Releases

Depression? Take the HERBALmax Mood $ Fatigue Formula

 

Depression? Take the HERBALmax Mood $ Fatigue Formula











(PRWEB) March 1, 2005

Approximately 20 million adults in the U.S. suffer from depression each year. About 1 in 6 American adults have had a serious episode of depression at some point during their lifetimes, according to statistics provided by the National Institute of Mental Health.

Dr. Zhang a former scientist for herbal pharmacology and a doctor in Chinese medicine created the formula. The Mood & Fatigue Formula has been tested over 10 years in clinical practice with hundreds of patients with depression and chronic fatigue; The formula has proven extremely effective with no side effects.

Michael Teruya, an architect, wrote: “I have suffered from depression for a year and had been taking several different medications. Dr. Zhang’s Mood & Fatigue pills instantly improve my outlook on life & I feel much happier & positive about everything.”

Joan Kerrigan “had suffered from depression since [she] was 14 years old” She began taking HERBALmax™ Mood & Fatigue formula, and for the “first time [she] did no suffer from seasonal depression.”

The Mood & Fatigue formula is made from pure Chinese herbal concentrates.

Scientific data indicates that people suffering from depression have imbalances of natural substances (known as neurotransmitters) that allow brain cells to communicate with one another. Some scientists think that low levels of one these neurotransmitters, serotonin, in the brain may contribute to the well-known symptoms of depression.

Prozac was the first of a class of drugs that was developed to treat depression. These so-called selective serotonin reuptake inhibitors (SSRI’s), work by raising levels of serotonin circulating in the brain. Since Prozac first came on the market in 1988, other similar drugs have been developed including Zoloft, Paxil, Celexa, and Effexor. These drugs have become enormously popular yet extremely controversial.

In recent years the use of SSRI drugs has been increasingly challenged because of safety concerns of these potentially hazardous drugs. In February of 2004, the British government banned SSRI use in children. In March of 2004, the FDA required that these drugs have labels warning that these anti-depressant medications can cause deepening depression and even suicide. It also noted other possible side effects including hostility. Coupled with other well-known side effects of common anti-depressant medication including weight gain, sexual dysfunction, and sleep disturbance (either insomnia or excessive drowsiness), it is not surprising that consumers are increasingly turning to herbal alternative approaches—including traditional Chinese Medicine—for the helping of mood and fatigue symptoms.

Herbs have long been a mainstay of Asian health care. Perhaps the first herbal medicine book to refer to depression and its treatment, “Jin Gui Yao Lue”, was written by a Chinese doctor in the 3rd century A.D. This formula and its underlying theory of the origins of depression have fluenced generations of practitioners of traditional Chinese Medicine. Few people are aware, however, that Chinese scientists, such as Dr. Zhang, continue to develop the modern science of herbal medicine.

Dr. Zhang has authored over 30 scientific articles as well as two books. Her comprehensive textbook, Complete Guide for Identifying and Characterizing Chinese Herbals was named one of the best scientific books by the Chinese Government when published in 1992. Dr. Zhang was also awarded First Prize for her research from the Chinese government in 1992. In 1994, Dr. Zhang arrived in the United States to receive her Best Paper Award from the First World Traditional Medicine Conference.

The Mood & Fatigue formula costs $ 15.95 a bottle with 50 capsules. The product can be purchased through www.herbal-max.com.

HERBALmax™ also has Heart formula, Blood pressure formula, Skin Formula, Liver formula, Acne formula, Cholesterol formula, Flu, Cough formula, menopause formula and male potency formula. For more information about these products, you can visit www.herbal-max.com or call Dr. Zhang at her Los Angeles office (310) 234-9689.

# # #



















VocusВ©Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.







Find More Effexor Press Releases

Children Suicide В“ClusterВ” in Pennsylvania is Antidepressant Use to Blame?

 

Children Suicide “Cluster” in Pennsylvania is Antidepressant Use to Blame?











(PRWEB) October 30, 2004

To say that suicide clusters have increased without addressing a possible antidepressant link is a “smoke screen” attempt to take our attention away from the stark reality, the shock, and horror that the average person would have to know that 3 children all attending the same school killed themselves all inside a 6 week period. One would think right away, what are the odds?

Psychologist Sara Camaerei, who practices with Family Treatment Associates of Stroudsburg, PA had this to say regarding the recent cluster of child suicides. “Suicide is a taboo in our society. No one likes to talk about it. When one individual commits suicide, it removes the taboo and others could think that maybe it’s an alternative.”

A taboo, simply put, is anything prohibited or forbidden by society, tradition or convention. To blame suicide on the fact that it is a taboo within society and that children are more likely to kill themselves because society as a whole does not like to talk about suicide is a far-reaching theory. To reach further and state that one child suicide would encourage other children to follow suit, simply killing themselves because this “taboo” has been removed, is another questionable theory that offers very little answers and does not get to the crux of the situation.    

The reality is that both statements produce a tremendous amount of much needed “smoke and mirrors” on the mental health industries part in their futile attempt to divert our focus away from more logical explanations. The reality is that both statements and point of view do not address the current antidepressant crisis happening in this country and the very real plausible explanation into why children are killing themselves at such a rapid rate.

The facts should speak for themselves and override any meager attempts by a profit driven industry to explain away child suicides. The facts should not be covered up or go unheard when children continue to die. They are:

·Last years ban of antidepressants for children in the U.K. due to their link to suicide ideations.

·This years FDA investigation into the antidepressant link to suicide and violence.

·This years Congressional Investigations into the FDA’s failure to act in the best interest of public safety by attempting to withhold crucial drug research and studies from the public.

·The drug companies ability to withhold clinical data from the FDA and the public that clearly linked antidepressant use with suicide.

·The recent issuance of “Black Box Warnings” by the FDA on all antidepressants clearly spelling out their link to suicide.

·Over 850 parents have come forward on a national level to report being pressured and coerced by nation schools to place their children on behavioral drugs and antidepressants http://www.ablechild.org/data/thelist.asp.

·Parents and advocates taking action within states across the nation to enact state laws outlawing the prevalent practice of coercion by schools which led to the Federal government proposing “The Child Medication Safety Act,” which would safeguard both parental and children’s rights http://ablechild.org/flegislation.htm.

·Lack of a tracking system in place for each State and for the Nation overall, that would comprise useful data regarding the number of children dying as a result of psychiatric drugs.

These facts cannot be discounted. The question remains: Is the American public going to continue to buy into the mental health industries “smokes and mirror” attempts to dispel, distort and overshadow children dying, and the reason why they are dying?

Is this incident at Pocono Mountain East High School in Pennsylvania so easily swept under the rug by the industry promoting unapproved drugs to children? Will the American public allow this to happen?

The American public needs to demand accountability. Three child “cluster” deaths in Pennsylvania should be enough to prompt a full Federal investigation into the matter. The public needs to have access into the number of children dying as a result of psychiatric drugs. No accountability and No oversight is just plain Unacceptable.

For more information on children’s mental health issues, Federal and State laws involving a child’s right to grow up drug free, and education please visit www.ablechild.org.

Patricia Weathers, President, 845-677-8115

Sheila Matthews, National Vice President 203-966-8419

# # #



















VocusВ©Copyright 1997-2010, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.







Acid Reflux: Is the Medication Worse Than the Condition? FLAVORx Finds the Solution.

 



Bethesda, MD (PRWEB) February 9, 2006

If you suffer from acid reflux you are in good company; Ashlee Simpson, John Elway, Joss Stone, Sam Donaldson, Jim Palmer, President Bill Clinton and President George Bush, all have acid reflux. Reflux sufferers have long endured not only the pain and discomfort of reflux symptoms, but also unpleasant and chalky, alcohol-heavy, strong peppermint-flavored medicine concoctions used to control the condition. Thankfully, FLAVORx Inc, the company that has specialized in developing medicinal flavorings for over 10 years, has made adjustments to accommodate commercially available liquid reflux medications that keep them safe and effective but are much more taste bud-friendly and less traumatic going down. Acid reflux and gastroesophageal reflux disease (GERD) are conditions that commonly affect adults, but are also seen in children (Rosie O’Donnell’s son, and Celine Dion’s son both suffer from acid reflux) and more specifically, infants. Reflux is extremely common in premature babies, and children with cystic fibrosis, muscular or neurological problems and conditions such as Down’s syndrome. The good news is that over 90% of children afflicted with reflux will eventually outgrow it. But until they do, FLAVORx is committed to providing a palatable and successful solution to the bitter and stinging taste sensation of commerically available medications.

The definition of “reflux” is the splashing or pushing of stomach contents backwards into the esophagus (and sometimes mouth and nose). This is the result of weakened muscle tissue surrounding the esophagus and stomach that allow stomach contents to flow backward. The most common complaint is heartburn, but other symptoms include vomiting, coughing, wheezing, recurrent pneumonia and even difficulty gaining weight. In infants, reflux is typically the result of an immature or underdeveloped digestive system. For older children and adults, gastrointestinal problems are typically associated with lifestyle choices such as improper diet, lack of exercise, smoking and excessive alcohol intake. Medications to neutralize stomach acid include antacids (Mylanta and Maalox), H2 acid blockers (Tagamet, Zantac and Pepcid) and enzyme-blocking proton-pump inhibitors (Prevacid, Prilosec, Nexium and Axid).

Zantac, one of the most popular H2 acid blockers, is available commercially in a syrup that is specifically beneficial to babies and children who can’t swallow tablets. However, Zantac syrup contains 7.5% alcohol (common alcoholic beverages like beer contain between 5-7%), a high level for children, and even some adults, especially if taking multiple doses. In addition, the active ingredient, Ranitidine HCl, has a very bitter taste and sulfur-like odor, which are both masked with a strong peppermint flavor that unfortunately carries an extremely powerful and stinging taste and sensation, especially to young palates.

After receiving many calls from parents regarding flavoring for Zantac syrup, FLAVORx retreated to its laboratories to study what flavors would pair best. Its strong peppermint flavor and high alcohol content made it difficult to work with so FLAVORx came up with a new solution. From Zantac tablets, FLAVORx researchers created a suspension using FLAVORx’s proprietary Sweetening Enhancer to make a sweet and sugar-free vehicle to cover up the bitter taste of the Ranitidine HCl. This suspension is easily manipulated to pair successfully with a multitude of flavors, including grape, raspberry and bubblegum.

Through further testing, FLAVORx researchers found that alkaline flavors such as grape and bubblegum retain the integrity and work best in proton-pump inhibitors such as Prevacid and Prilosec while the Sweetening Enhancer decreases bitterness and saltiness. Depending on the vehicles and excipients used, the suspension is stable if kept in the refrigerator for 14 days without fear of decrease in efficacy.

Because FLAVORx President and CEO, Kenny Kramm experienced the burdens of GERD with his youngest daughter Hadley, he was particularly dedicated to finding the right solutions to treat acid reflux. “The sleepless nights, the pain and helplessness of a young child dealing with severe reflux are absolutely heartbreaking. As a parent, it’s exhausting. As a company, I knew we needed to, and hoped that we would successfully be able to, do something to help these kids and parents worldwide.”

To express your opinions on reflux treatment, take the Acid Reflux and GERD survey by clicking on http://www.surveymonkey.com/s.asp?u=907031756479. To learn more about acid reflux or GERD, visit www.reflux.org, an online resource for parents and children.

For FLAVORx information visit www.flavorx.com or please contact Teresa Chen at 800.884.5771, extension 234.

# # #